Cargando…
Diagnostic Value of Circulating Progranulin and Its Receptor EphA2 in Predicting the Atheroma Burden in Patients with Coronary Artery Disease
BACKGROUND: Progranulin (PGRN) and its potential receptor Eph-receptor tyrosine kinase-type A2 (EphA2) are inflammation-related molecules that present on the atherosclerotic plaques. However, the roles of circulating PGRN and EphA2 in coronary artery disease (CAD) remain unclear. OBJECTIVE: To study...
Autores principales: | Tian, Dan, Qin, Qing, Liu, Ruiyan, Wang, Zi, Li, Xiaoyu, Xu, Qing, Lv, Qianzhou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084646/ https://www.ncbi.nlm.nih.gov/pubmed/33968283 http://dx.doi.org/10.1155/2021/6653501 |
Ejemplares similares
-
Homocysteine Impairs Endothelial Cell Barrier Function and Angiogenic Potential via the Progranulin/EphA2 Pathway
por: Tian, Dan, et al.
Publicado: (2021) -
EphA2 is a functional receptor for the growth factor progranulin
por: Neill, Thomas, et al.
Publicado: (2016) -
Progranulin and the receptor tyrosine kinase EphA2, partners in crime?
por: Chitramuthu, Babykumari, et al.
Publicado: (2016) -
EphA5 and EphA6: regulation of neuronal and spine morphology
por: Das, Gitanjali, et al.
Publicado: (2016) -
Ephrin Receptors (Eph): EphA1, EphA5, and EphA7 Expression in Uveal Melanoma—Associations with Clinical Parameters and Patient Survival
por: Gajdzis, Malgorzata, et al.
Publicado: (2020)